Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2015

View Archived Issues

Safety and toxicity results presented for pralatrexate plus oxaliplatin combination treatment

Cabozantinib S-malate shows limited activity in advanced CCA patients

Combination of pimasertib and gemcitabine fails to improve PFS

PF-04136309 and FOLFIRINOX shows no additional toxicity in pancreatic adenocarcinoma

Selective cannabinoid CB1 receptor antagonism improves diabetic nephropathy

Jakavi recommended for approval in Europe for polycythemia vera

Senshio approved in Europe for vulvar and vaginal atrophy

Data and safety monitoring board recommends continuation of phase II masitinib

ISIS-416858 shows potential to decrease postoperative thrombosis

Researchers at BMS disclose new ROCK-2 inhibitors

Calibr patents novel dimeric compounds for COPD and cystic fibrosis

Millennium Pharmaceuticals reports SUMO-activating enzyme inhibitors

New cyclin-G-associated kinase ligands designed at KU Leuven

ZIOPHARM Oncology presents ongoing projects

Scientists in Japan prepare and test novel P2X4 antagonists for pain

Merck & Co. completes Cubist tender offer

Array BioPharma to acquire worldwide rights to encorafenib

EMA committee recommends approval of Saxenda for weight management

EMA recommends approval of Abraxane for NSCLC

FDA accepts Praluent BLA for priority review

European CHMP recommends new approval of Eylea

Neomed receives approval to begin phase I trial of NEO-6860

Galapagos receives grant for antibiotic research

FDA approves Bexsero meningitis B vaccine

The Medicines Company receives CHMP recommendations for three acute care products

FDA grants fast track designation to intrathecally idursulfase

Cubist's tedizolid phosphate recommended for approval in E.U. for ABSSSI

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...